RESUMO
Undoubtedly there has been good progress in finding some drugs that fight HIV infection. The list of some of these drugs includes: AZT, ddC, ddl, 3TC and Protease inhibitors [e.g. Indinavir, ritanovir, Saquinavir] during the last few years; however the age of antiviral monotherapy for HIV infection is over. Several clinical trials have shown clinical endpoint benefit both in terms of progression and survival using a combination of antiviral agents i.e. there is growing evidence that combination therapy is the way forward in HIV treatment. Triple combination is considered a new therapeutic approach and by applying some advanced Laboratory Investigations e.g. CD 4 count, viral load measurement etc, these techniques can guide the treating doctor to a proper evaluation of the progress of the condition of his patient. Prophylaxis and treatment of the most common opportunistic infections have also added to the benefit for AIDS patients